UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB

UBS Reports Q1 2026 Net Profit of $3 Billion, Exceeding Expectations

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

MetaVia

Arcadia Biosciences

Silexion Therapeutics

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

SCDL

UCIB

Swiss bank UBS reported a first-quarter net profit of US$3 billion for 2026, an 80% increase year-on-year, surpassing analyst expectations of US$2.3 billion. The growth was driven by record trading revenue amid market volatility due to the Middle East conflict. Investment banking revenue rose 27%, while global wealth management attracted US$37 billion in new assets. UBS plans to repurchase at least US$3 billion in shares this year and is on track to complete the integration of Credit Suisse, aiming for further efficiency gains.

Businesstimes News

ETRACS 2x Leveraged US Div Fctr TR ETN

UBS Group AG

UBS beats profit expectations on market volatility

JABS

DABS

FNCL

UBS has maintained a Hold rating on MarketWise (MKTW) with a price target of $20.00, while the shares closed at $18.15. Additionally, TipRanks also issued a Hold rating for MarketWise, but upgraded it to a Buy on the same day.

Tip Ranks

Janus Henderson Asset-Backed Secs ETF

VG Financial

ISHRS Us Brokers & Sec Exchg

DoubleLine Asset-Backed Securities ETF

Financial Select Sector SPDR Fund

iShares Frontier and Select EM ETF

Fidelity MSCI Financials Index

UBS Remains a Hold on MarketWise (MKTW)

UBS has received positive signals from a group of parliamentarians regarding the upcoming banking stability regulations. Informal discussions suggest that the strict capital requirements proposed by the Federal Council may be softened. UBS is concerned that the current proposals could hinder its competitiveness compared to banks in the US and UK. The Federal Department of Finance previously rejected a compromise proposal, but lawmakers are expected to take a more active role in negotiations starting in May. UBS has not commented on the situation, and the final outcome remains uncertain.

FiNews

UBS Receives Reassuring Signals from Parliament

515020

512000

516210

UBS Group AG exits substantial shareholder position in Elsight Limited

ChinaAMC CSI Banks ETF

Hwabao WP CSI All Share Investment Banking & Brokerage ETF

Hwabao WP CSI Banks ETF

Fullgoal CSI 800 Banks ETF

WP CSI Banks ETF

Huaan CSI Banks ETF

UBS Group AG exits substantial shareholder position in Elsight Limited

UBS Asset Management has appointed Raymond Ma, a former Invesco portfolio manager, to its China equities team as deputy to Bin Shi. Ma, based in Hong Kong, previously served as chief investment officer for mainland China and Hong Kong at Invesco and has 15 years of experience at Fidelity. The memo highlights the long-standing professional relationship between Ma and Shi, emphasizing their shared investment philosophy.

UBS AM Adds Ex-Invesco China Equities Portfolio Manager

Intech Investment Management LLC acquired 183,082 shares of UBS Group AG, valued at approximately $7.48 million, during the 3rd quarter. Other institutional investors, including Norges Bank and Massachusetts Financial Services, also adjusted their stakes in UBS. UBS has faced mixed sentiments, with positive news regarding client migration from Credit Suisse and negative warnings about potential credit default rates. Analysts have varied ratings on UBS, with a consensus rating of "Moderate Buy" and an average price target of $60.30.

Market Beat

Intech Investment Management LLC Purchases Shares of 183,082 UBS Group AG $UBS

UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB(UCIB.US)

UBS beats profit expectations on market volatility

UBS Remains a Hold on MarketWise (MKTW)

UBS Receives Reassuring Signals from Parliament

UBS Group AG exits substantial shareholder position in Elsight Limited

UBS AM Adds Ex-Invesco China Equities Portfolio Manager